Calculated Tumor Volume Is an Independent Predictor of Biochemical Recurrence in Patients Who Underwent Retropubic Radical Prostatectomy

od Tanaka, Nobumichi, Fujimoto, Kiyohide, Hirayama, Akihide, Nakai, Yasushi, Chihara, Yoshitomo, Anai, Satoshi, Tomioka, Atsushi, Shimada, Keiji, Konishi, Noboru, Hirao, Yoshihiko
Izdano 2012

Novel missense mutation in the FH gene in familial renal cell cancer patients lacking cutaneous leiomyomas

od Kuwada, Masaomi, Chihara, Yoshitomo, Lou, Yi, Torimoto, Kazumasa, Kagebayashi, Yoriaki, Tamura, Kenji, Shuin, Taro, Fujimoto, Kiyohide, Kuniyasu, Hiroki, Samma, Shoji
Izdano 2014

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer

od Tomioka, Atsushi, Tanaka, Nobumichi, Yoshikawa, Motokiyo, Miyake, Makito, Anai, Satoshi, Chihara, Yoshitomo, Okajima, Eijiro, Hirayama, Akihide, Hirao, Yoshihiko, Fujimoto, Kiyohide
Izdano 2014

Photodynamic diagnosis of shed prostate cancer cells in voided urine treated with 5-aminolevulinic acid

od Nakai, Yasushi, Anai, Satoshi, Kuwada, Masaomi, Miyake, Makito, Chihara, Yoshitomo, Tanaka, Nobumichi, Hirayama, Akihide, Yoshida, Katsunori, Hirao, Yoshihiko, Fujimoto, Kiyohide
Izdano 2014

Diagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancer

od Miyake, Makito, Nakai, Yasushi, Anai, Satoshi, Tatsumi, Yoshihiro, Kuwada, Masaomi, Onishi, Sayuri, Chihara, Yoshitomo, Tanaka, Nobumichi, Hirao, Yoshihiko, Fujimoto, Kiyohide
Izdano u Cancer Sci (2014)

Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy

od Tomioka, Atsushi, Tanaka, Nobumichi, Yoshikawa, Motokiyo, Miyake, Makito, Anai, Satoshi, Chihara, Yoshitomo, Okajima, Eijiro, Hirayama, Akihide, Hirao, Yoshihiko, Fujimoto, Kiyohide
Izdano u BMC Cancer (2015)

Diagnostic markers of urothelial cancer based on DNA methylation analysis

od Chihara, Yoshitomo, Kanai, Yae, Fujimoto, Hiroyuki, Sugano, Kokichi, Kawashima, Kiyotaka, Liang, Gangning, Jones, Peter A, Fujimoto, Kiyohide, Kuniyasu, Hiroki, Hirao, Yoshihiko
Izdano 2013

Unique DNA methylation patterns distinguish non-invasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue

od Wolff, Erika M., Chihara, Yoshitomo, Pan, Fei, Weisenberger, Daniel J., Siegmund, Kimberly D., Sugano, Kokichi, Kawashima, Kiyotaka, Laird, Peter W., Jones, Peter A., Liang, Gangning
Izdano 2010

Expression of MAS1 in breast cancer

od Luo, Yi, Tanabe, Eriko, Kitayoshi, Misaho, Nishiguchi, Yukiko, Fujiwara, Rina, Matsushima, Sayako, Sasaki, Takamitsu, Sasahira, Tomonori, Chihara, Yoshitomo, Nakae, Dai, Fujii, Kiyomu, Ohmori, Hitoshi, Kuniyasu, Hiroki
Izdano u Cancer Sci (2015)

Reprogramming of the human intestinal epigenome by surgical tissue transposition

od Lay, Fides D., Triche, Timothy J., Tsai, Yvonne C., Su, Sheng-Fang, Martin, Sue Ellen, Daneshmand, Siamak, Skinner, Eila C., Liang, Gangning, Chihara, Yoshitomo, Jones, Peter A.
Izdano 2014

Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples

od Piatti, Paolo, Chew, Yap Ching, Suwoto, Michiko, Yamada, Taikun, Jara, Benjamin, Jia, Xi-Yu, Guo, Wei, Ghodoussipour, Saum, Daneshmand, Siamak, Ahmadi, Hamed, Rice, Jeffrey, Bhasin, Jeffrey, Holloway, Faith, Tsai, Yvonne, Chihara, Yoshitomo, Liang, Gangning
Izdano u Clin Epigenetics (2021)

Diagnostic and prognostic role of urinary collagens in primary human bladder cancer

od Miyake, Makito, Morizawa, Yosuke, Hori, Shunta, Tatsumi, Yoshihiro, Onishi, Sayuri, Owari, Takuya, Iida, Kota, Onishi, Kenta, Gotoh, Daisuke, Nakai, Yasushi, Anai, Satoshi, Chihara, Yoshitomo, Torimoto, Kazumasa, Aoki, Katsuya, Tanaka, Nobumichi, Shimada, Keiji, Konishi, Noboru, Fujimoto, Kiyohide
Izdano u Cancer Sci (2017)